Akebia Therapeutics
AKBA
#9606
Rank
โ‚ฌ97.53 M
Marketcap
0,35ย โ‚ฌ
Share price
-8.71%
Change (1 day)
-74.52%
Change (1 year)

Market capitalization of Akebia Therapeutics (AKBA)

Market cap: โ‚ฌ97.53 Million

As of November 2026 Akebia Therapeutics has a market cap of โ‚ฌ97.53 Million. This makes Akebia Therapeutics the world's 9606th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Akebia Therapeutics from 2014 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ97.53 M-73.99%
2025โ‚ฌ0.37 B-8.28%
2024โ‚ฌ0.40 B93.48%
2023โ‚ฌ0.21 B113.55%
2022โ‚ฌ98.95 M-71.66%
2021โ‚ฌ0.34 B6.11%
2020โ‚ฌ0.32 B-52.07%
2019โ‚ฌ0.68 B21.49%
2018โ‚ฌ0.56 B-3.55%
2017โ‚ฌ0.58 B54.45%
2016โ‚ฌ0.37 B4.69%
2015โ‚ฌ0.36 B85.84%
2014โ‚ฌ0.19 B

End of Day market cap according to different sources

On Nov 20th, 2026 the market cap of Akebia Therapeutics was reported to be:

โ‚ฌ97.53 Million
by Nasdaq info icon info icon
โ‚ฌ97.53 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ593.28 B 608,185.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ258.94 B 265,392.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚ฌ214.71 B 220,045.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
โ‚ฌ0.94 B 865.33%๐Ÿ‡บ๐Ÿ‡ธ USA